How Werum PAS-X MES kept AstraZeneca's manufacturing operations running during COVID-19

Case study

Interview with AstraZeneca on the benefits of digitized processes for business resilience.

Share

virus on a blue background

Results

Manufacturing continued without disruption during COVID-19

Werum PAS-X MES enabled AstraZeneca’s biologics site in Frederick to keep production running seamlessly despite pandemic restrictions, with no impact on output. 

Remote access empowered teams and ensured safety

Production and quality teams could access PAS-X remotely for batch reviews and releases, minimizing on-site presence and protecting employee health.

Critical batch data always available in real time

Real-time visibility into batch status and digital workflows eliminated reliance on paper, supporting decisions and operational continuity under remote work conditions. 

Unlock the full case study

Get the full details on the challenges and extraordinary outcomes. Download the complete case study.